Alabama Doctor Pleads Guilty to $6 Million Telemedicine Health Care Fraud Scheme
Department of Justice, U.S. Attorney's Office, Massachusetts. Published November 13, 2025; the action is dated October 1, 2025.
Robinson worked with telemedicine companies to sign pre-populated orders for medically unnecessary durable medical equipment and genetic testing for Medicare beneficiaries he did not contact, resulting in over $6 million in claims submitted to Medicare.
Providers named in this release
Matched to the national provider registry by name, place and provider type at high confidence only. Each opens the provider's own record.
1TOMMIE ROBINSONOwens Cross Roads, AL$33KBOSTON to An Alabama-based doctor pleaded guilty on Oct. 1, 2025 in federal court in Boston to a $6 million telemedicine fraud scheme involving medically unnecessary durable medical equipment (DME) and genetic testing primarily used to detect mutations in genes that could indicate a higher risk of developing certain types of cancers. Tommie Robinson, 43, pleaded guilty to one count of health care fraud. U.S.
Senior District Court Judge Nathaniel M. Gorton scheduled sentencing for Jan. 14, 2026. Robinson was charged in August 2025 .
Between December 2018 and March 2021, Robinson worked with telemedicine companies to sign medical documentation, including doctors’ orders, for medically unnecessary durable medical equipment and genetic testing. The orders Robinson signed were pre-populated based on telemarketing calls made to Medicare beneficiaries. Robinson generally did not contact the beneficiaries himself and had no medical relationship with the beneficiaries.
DME suppliers and laboratories ultimately submitted claims to Medicare for these signed orders. As a result of Robinson’s participation in this scheme, over $6 million in claims were submitted to Medicare for DME and genetic testing that were medically unnecessary, based on false documentation and tainted by kickbacks. The charge of health care fraud provides for a sentence of up to 10 years in prison, up to three years of supervised release, and a fine of up to $250,000 or twice the gross pecuniary gain or loss, whichever is greater.
Sentences are imposed by a federal district court judge based upon the U.S. Sentencing Guidelines and statutes which govern the determination of a sentence in a criminal case. United States Attorney Leah B.
Foley; Robert Coviello, Special Agent in Charge, Health and Human Services-Office of Inspector General; Ted E. Docks, Special Agent in Charge, Federal Bureau of Investigations, Boston Division; Ketty Larco-Ward, Inspector in Charge, United States Postal Inspection Service, Boston Division; Kelly M. Lawson, Acting Regional Director, U.S.
Department of Labor, Employee Benefits Security Administration, Boston Regional Office; and Patrick Hegarty, Special Agent in Charge, Defense Criminal Investigation Service, North East Field Office made the announcement. Assistant U.S. Attorney Howard Locker of the Health Care Fraud Unit and Alexandra Brazier and Lindsey Ross of the Affirmative Civil Enforcement Units are prosecuting the case.